SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,154,000 | +47.2% | 12,679 | 0.0% | 0.72% | +17.1% |
Q1 2020 | $1,463,000 | -32.5% | 12,679 | -68.7% | 0.61% | -34.3% |
Q4 2017 | $2,166,000 | -1.7% | 40,495 | 0.0% | 0.94% | -5.0% |
Q3 2017 | $2,203,000 | +50.2% | 40,495 | +42.8% | 0.98% | +47.3% |
Q2 2017 | $1,467,000 | -27.7% | 28,351 | -12.2% | 0.67% | -17.3% |
Q1 2017 | $2,029,000 | +78.0% | 32,284 | -9.0% | 0.81% | +50.5% |
Q4 2014 | $1,140,000 | -13.6% | 35,489 | 0.0% | 0.54% | +26750.0% |
Q3 2014 | $1,319,000 | -2.8% | 35,489 | 0.0% | 0.00% | -99.8% |
Q2 2014 | $1,357,000 | – | 35,489 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |